Chlorhexidine

Synonyms: 氯己定
Chlorhexidine 是一种口服有效、靶向微生物细胞膜的阳离子抗菌剂,通过与细胞膜磷脂非特异性结合破坏膜结构并诱导细胞内容物泄漏,对革兰氏阳性/阴性菌均具广谱杀菌活性,并可干扰膜通透性、导致蛋白质沉淀及能量代谢障碍,从而快速抑制微生物生长并诱导细胞死亡(坏死 (necroptosis) 或凋亡 (apoptosis))。
产品编号: MS-O38936 纯度: 99.60% CAS No.: 55-56-1 分子式: C22H30Cl2N10 分子量: 505.45
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
100mg
询价
3-5 天
500mg
询价
3-5 天
1g
询价
3-5 天
5g
询价
询价
10g
询价
询价

产品描述

Chlorhexidine 是一种口服有效、靶向微生物细胞膜的阳离子抗菌剂,通过与细胞膜磷脂非特异性结合破坏膜结构并诱导细胞内容物泄漏,对革兰氏阳性/阴性菌均具广谱杀菌活性,并可干扰膜通透性、导致蛋白质沉淀及能量代谢障碍,从而快速抑制微生物生长并诱导细胞死亡(坏死 (necroptosis) 或凋亡 (apoptosis))。

生物实验数据

生物活性 Chlorhexidine is an orally active cationic antibacterial agent targeting microbial cell membranes that, through non-specific binding to membrane phospholipids, disrupts membrane structure and induces leakage of cellular contents, exhibiting broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria, and can interfere with membrane permeability, cause protein precipitation and energy metabolism impairment, thereby rapidly inhibiting microbial growth and inducing cell death (necroptosis or apoptosis).
体外研究
(In Vitro)

1. Cell death assay:
Chlorhexidine (0.000125%-0.016%; 24 h) induces cell death in L929 fibroblasts, inducing a pattern of cell necrosis and/or apoptosis, as well as cell stress. Furthermore, Chlorhexidine induces apoptosis at lower concentrations and necrosis at higher concentrations, and increases the expression of heat shock protein 70 (a marker of cell stress). Chlorhexidine may have an adverse effect on the resolution of apical periodontitis.
2. Cell viability experiment:
Chlorhexidine (0.0005%-0.5%; 30 min) causes the death of canine embryonic fibroblasts with concentration of ≥0.013%, while allows the cells to survive with concentration of ≤0.006%.
3. Bacterial survival experiment:
Chlorhexidine (0.0005%-0.5%; 30 min) has a concentration-dependent bactericidal effect on Staphylococcus aureus, and kills Staphylococcus aureus with concentration of ≥0.05%, while allows the bacteria to survive with concentration of ≤0.03%.

Cell Viability Assay

Cell Line: Canine embryonic fibroblasts
Concentration: 0.5%, 0.05%, 0.03%, 0.013%, 0.006%, 0.005%, 0.0005%
Incubation Time: 30 min
Result: Fibroblasts showed 0% survival at concentrations ≥0.013%, while concentrations ≤0.006% allowed significant survival (e.g., 74% survival at 0.0005%), indicating a concentration-dependent cytotoxic effect.
体内研究
(In Vivo)

Chlorhexidine (ip) 可减少小鼠结肠手术结束时的术后腹腔内感染。

Animal Model: Male Balb/c mice (4 weeks old, 20 g), paw subplantar injection model
Dosage: 0.125%, 0.25%, 0.5%, 1.0% Chlorhexidine in distilled water
Administration: Subplantar injection into the right hind paw, single dose, observed at 24 h, 48 h, 7 days, and 14 days
Result: At 0.5% and 1.0%, caused extensive coagulative necrosis in the epidermis, dermis, and subcutaneous tissue, associated with marked neutrophilic inflammation and edema at 24-48 h; 0.25% induced focal necrosis in few specimens and moderate inflammation in all; 0.125% caused no necrosis but moderate neutrophilic inflammation and edema.
Epidermal healing was complete by 7-14 days, with residual mononuclear cell infiltration and fibrous tissue thickening in high-dose groups.
Animal Model: C57BL/6J mice (6-8 weeks old), intratracheal instillation-induced lung injury model
Dosage: 0.125% (2.5 mg/kg), 0.25% (5 mg/kg), 0.5% (10 mg/kg), 1% (20 mg/kg) Chlorhexidine gluconate in RO water
Administration: Single intratracheal instillation via MicroSprayer Aerosolizer, observed for 8 weeks
Result: Led to dose-dependent lung tissue damage, including inflammatory cell infiltration, alveolar protein deposition, and airway epithelial cell exfoliation.
Increased collagen fiber deposition in the alveolar septum and bronchial stroma, with significantly higher lung organ coefficients in high-dose groups.
Decreased respiratory system compliance (Crs) and forced vital capacity (FVC), indicating restrictive ventilatory dysfunction.
Upregulated genes related to extracellular matrix organization (e.g., P4ha3) and mucus secretion (e.g., Muc5b, Muc5ac).
性状 固体
颜色 White to off-white

化学信息

分子量 505.45
分子式 C22H30Cl2N10
CAS No. 55-56-1
别名 氯己定

储存&溶解度

体内实验配方
10% DMSO+90% Saline: < 2.27 mg/mL (4.49 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.27 mg/mL (4.49 mM), Solution.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式

4°C, protect from light

*In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 25 mg/mL (49.46 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM1.9784 mL9.8922 mL19.7844 mL49.4609 mL
5 mM0.3957 mL1.9784 mL3.9569 mL9.8922 mL
10 mM0.1978 mL0.9892 mL1.9784 mL4.9461 mL
15 mM0.1319 mL0.6595 mL1.3190 mL3.2974 mL
20 mM0.0989 mL0.4946 mL0.9892 mL2.4730 mL
25 mM0.0791 mL0.3957 mL0.7914 mL1.9784 mL
30 mM0.0659 mL0.3297 mL0.6595 mL1.6487 mL
40 mM0.0495 mL0.2473 mL0.4946 mL1.2365 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础